SpyGlass Pharma, Inc. (SGP) — Financial Flexibility Index
SpyGlass Pharma, Inc. (SGP) has a Financial Flexibility Index of -1.17x as of June 2026. Free cash flow of $-12.91 Million (operating CF $-14.84 Million minus capex $1.93 Million) represents -1% of total liabilities ($11.07 Million). Check SGP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SpyGlass Pharma, Inc. Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for SpyGlass Pharma, Inc. across 3 annual periods. For the full cash flow conversion analysis, see SGP cash flow conversion.
Annual Financial Flexibility Index for SpyGlass Pharma, Inc. (2023–2025)
Year-by-year free cash flow to debt coverage for SpyGlass Pharma, Inc.. Explore SGP debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.15x | $-31.91 Million | $-32.70 Million | $214.70 Million | ▲ +37.8% |
| 2024 | -0.24x | $-20.04 Million | $-22.03 Million | $83.79 Million | ▼ -47.0% |
| 2023 | -0.16x | $-12.06 Million | $-12.28 Million | $74.13 Million | — |